Management of Hyponatremia in Heart Failure: Practical Considerations
- PMID: 36675801
- PMCID: PMC9865833
- DOI: 10.3390/jpm13010140
Management of Hyponatremia in Heart Failure: Practical Considerations
Abstract
Hyponatremia is commonly encountered in the setting of heart failure, especially in decompensated, fluid-overloaded patients. The pathophysiology of hyponatremia in patients with heart failure is complex, including numerous mechanisms: increased activity of the sympathetic nervous system and the renin-angiotensin-aldosterone system, high levels of arginine vasopressin and diuretic use. Symptoms are usually mild but hyponatremic encephalopathy can occur if there is an acute decrease in serum sodium levels. It is crucial to differentiate between dilutional hyponatremia, where free water excretion should be promoted, and depletional hyponatremia, where administration of saline is needed. An inappropriate correction of hyponatremia may lead to osmotic demyelination syndrome which can cause severe neurological symptoms. Treatment options for hyponatremia in heart failure, such as water restriction or the use of hypertonic saline with loop diuretics, have limited efficacy. The aim of this review is to summarize the principal mechanisms involved in the occurrence of hyponatremia, to present the main guidelines for the treatment of hyponatremia, and to collect and analyze data from studies which target new treatment options, such as vaptans.
Keywords: arginine vasopressin; conivaptan; dilutional; heart failure; hypertonic saline; hyponatremia; loop diuretics; osmotic demyelination syndrome; tolvaptan; vaptans.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Hyponatremia in Heart Failure: Pathogenesis and Management.Curr Cardiol Rev. 2019;15(4):252-261. doi: 10.2174/1573403X15666190306111812. Curr Cardiol Rev. 2019. PMID: 30843491 Free PMC article. Review.
-
Vaptans and hyponatremia in critical patients.Transl Med UniSa. 2012 Apr 30;3:1-14. Print 2012 May. Transl Med UniSa. 2012. PMID: 23905047 Free PMC article.
-
Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure.Am J Cardiol. 2005 May 2;95(9A):14B-23B. doi: 10.1016/j.amjcard.2005.03.004. Am J Cardiol. 2005. PMID: 15847853 Review.
-
Hyponatremia in acute decompensated heart failure: depletion versus dilution.J Am Coll Cardiol. 2015 Feb 10;65(5):480-92. doi: 10.1016/j.jacc.2014.12.010. J Am Coll Cardiol. 2015. PMID: 25660927 Review.
-
[Vasopressin antagonists in treatment of hyponatremia].Pol Arch Med Wewn. 2007 Aug;117(8):356-62. Pol Arch Med Wewn. 2007. PMID: 18018383 Review. Polish.
Cited by
-
Association between hyponatremia and adverse clinical outcomes of heart failure: current evidence based on a systematic review and meta-analysis.Front Cardiovasc Med. 2023 Dec 22;10:1339203. doi: 10.3389/fcvm.2023.1339203. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 38204798 Free PMC article.
-
Importance of early use of tolvaptan in hyponatremic acutely decompensated heart failure patients, a retrospective study.Egypt Heart J. 2025 Jan 13;77(1):10. doi: 10.1186/s43044-024-00603-1. Egypt Heart J. 2025. PMID: 39804452 Free PMC article.
-
Role of Vasoactive Hormone-Induced Signal Transduction in Cardiac Hypertrophy and Heart Failure.Cells. 2024 May 17;13(10):856. doi: 10.3390/cells13100856. Cells. 2024. PMID: 38786079 Free PMC article. Review.
-
Case report: Acute severe hyponatremia-induced seizures in a newborn: a community-acquired case and literature review.Front Pharmacol. 2024 Jun 17;15:1391024. doi: 10.3389/fphar.2024.1391024. eCollection 2024. Front Pharmacol. 2024. PMID: 38957388 Free PMC article.
-
Tolvaptan for water retention in heart failure: a systematic review.Syst Rev. 2023 Jul 29;12(1):130. doi: 10.1186/s13643-023-02293-3. Syst Rev. 2023. PMID: 37516894 Free PMC article.
References
-
- Gheorghiade M., Abraham W.T., Albert N.M., Gattis Stough W., Greenberg B.H., O’Connor C.M., She L., Yancy C.W., Young J., Fonarow G.C. Relationship between Admission Serum Sodium Concentration and Clinical Outcomes in Patients Hospitalized for Heart Failure: An Analysis from the OPTIMIZE-HF Registry. Eur. Heart J. 2007;28:980–988. doi: 10.1093/eurheartj/ehl542. - DOI - PubMed
-
- Konishi M., Haraguchi G., Ohigashi H., Sasaoka T., Yoshikawa S., Inagaki H., Ashikaga T., Isobe M. Progression of Hyponatremia Is Associated with Increased Cardiac Mortality in Patients Hospitalized for Acute Decompensated Heart Failure. J. Card. Fail. 2012;18:620–625. doi: 10.1016/j.cardfail.2012.06.415. - DOI - PubMed
-
- Gheorghiade M., Rossi J.S., Cotts W., Shin D.D., Hellkamp A.S., Piña I.L., Fonarow G.C., DeMarco T., Pauly D.F., Rogers J., et al. Characterization and Prognostic Value of Persistent Hyponatremia in Patients with Severe Heart Failure in the ESCAPE Trial. Arch. Intern. Med. 2007;167:1998–2005. doi: 10.1001/archinte.167.18.1998. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources